Search results
Results from the WOW.Com Content Network
The company was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Herbert Boyer. [ 9 ] [ 10 ] Boyer is considered to be a pioneer in the field of recombinant DNA technology. In 1973, Boyer and his colleague Stanley Norman Cohen demonstrated that restriction enzymes could be used as "scissors" to cut DNA fragments of ...
Stanley Norman Cohen (born February 17, 1935) is an American geneticist [2] and the Kwoh-Ting Li Professor in the Stanford University School of Medicine. [3] Stanley Cohen and Herbert Boyer were the first scientists to transplant genes from one living organism to another, a fundamental discovery for genetical engineering.
pSC101. pSC101 is a DNA plasmid that is used as a cloning vector in genetic cloning experiments. pSC101 was the first cloning vector, used in 1973 by Herbert Boyer and Stanley Norman Cohen. Using this plasmid they have demonstrated that a gene from a frog could be transferred into bacterial cells and then expressed by the bacterial cells.
Herbert Boyer and Stanley Cohen made the first genetically modified organism in 1973, a bacterium resistant to the antibiotic kanamycin. The first genetically modified animal, a mouse, was created in 1974 by Rudolf Jaenisch, and the first plant was produced in 1983.
978-1-4767-3350-0 (Hardcover) The Gene: An Intimate History is a book written by Siddhartha Mukherjee, an Indian-born American physician and oncologist. It was published on 17 May 2016 by Scribner. [ 1 ] The book chronicles the history of the gene and genetic research, all the way from Aristotle to Crick, Watson and Franklin and then the 21st ...
The first GMO was a bacterium generated by Herbert Boyer and Stanley Cohen in 1973. Rudolf Jaenisch created the first GM animal when he inserted foreign DNA into a mouse in 1974. The first company to focus on genetic engineering, Genentech, was founded in 1976 and started the production of human proteins.
By 1978 Herbert Boyer's biotechnology startup Genentech had contracted with Riggs and Itakura, [4] and Boyer and Itakura had created a plasmid coded for human insulin. Genentech signed a joint-venture agreement with Eli Lilly and Company to develop and market the technology.
The "Cohen/Boyer patents" were invented by Stanley Cohen of Stanford University and Herbert Boyer of University of California, San Francisco. [14] [15] [16] The patents cover inventions for splicing genes to make recombinant proteins that are foundational to the biotechnology industry. [17]